Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001883850-23-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-05-17 | 2023-05-15 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 65.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | G | D | 53,807 | $0.00 | 0 | I 2021 GRAT | — | — | |
| 2 | Common | Common Stock | 2023-05-15 | G | A | 53,807 | $0.00 | 64,985 | I By Trust | — | — |